Analysis Highlights from 2021 ACSM Digital Annual Assembly: Train in Regenerative Drugs

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Newswise – This year’s ACSM World Congress on Fundamentals of Movement in Regenerative Medicine focuses on the latest scientific discoveries in this rapidly evolving area. Chaired by Marcas M. Bamman, Ph.D., FACSM, of the University of Alabama at Birmingham, this world congress brings together leading scientists in and out of the field to discuss advances in the field on a range of diseases and conditions . The program schedule includes sessions on disease-specific focuses at multiple levels of scientific research (e.g. animal models, clinical studies, interactions between sports drugs and devices, etc.).

Here is a selection of the research results presented by experts:

Can we delay the progression of the signs of Parkinson’s disease? The dose-response SPARX3 study. The benefits of exercise for Parkinson’s disease (PD) are known, but the optimal dose for effectiveness is unknown. Daniel Corcos, Ph.D., of Northwestern University, will give this keynote address and discuss the recently funded NIH clinical trial SPARX3, which investigates the dose response of cardio exercise for people with Parkinson’s disease. Topics include: studies of training in animal models of Parkinson’s disease, studies of endurance training for Parkinson’s disease in humans, the multi-site study design of SPARX3, and potential mediators for the effectiveness of the training.

Neurodegenerative Disease II: Alzheimer’s Disease and Dementia. The number of people affected by Alzheimer’s and neurodegenerative diseases continues to grow rapidly as our population ages. Growing evidence suggests that exercise affects a person’s risk of Alzheimer’s and can affect neurodegeneration. This session will examine mechanisms that link exercise to neuroplasticity, neuroinflammation, and brain function, as well as how exercise can be a strategy to delay the onset of Alzheimer’s in healthy individuals and slow it down in those affected. Presented by Zurine De Miguel, Ph.D., Stanford University; Constanza J. Cortes, Ph.D., University of Alabama, Birmingham; Henriette van Praag, Ph.D., Florida Atlantic University; Jeffrey Burns, MD, MS, University of Kansas Medical Center.

Regenerative rehabilitation: physical medicine meets stem cell therapeutics. It has been shown that regenerative medical technologies benefit from the application of targeted and specific mechanical stimuli, a mainstay of rehabilitation. Accordingly, physical therapeutics can be enhanced by cellular and other regenerative therapies. The integration of these two disciplines – known as regenerative rehabilitation – has the potential to improve the effectiveness of interventions to optimize functional recovery after injury and disease development. Presented by Fabrisia Ambrosio, Ph.D., MPT, University of Pittsburgh Medical Center.

Additional tutorials, symposia, and poster sessions cover topics such as:

  • Cancer, stroke, and cerebrovascular disease
  • Basic and translation studies
  • Regenerative medicine and rehabilitation
  • Neurodegenerative Diseases
  • Metabolic disease
  • Exercise and Mitochondrial Medicine
  • Cardiovascular aging and remodeling
  • Molecular Discoveries

See the schedule for the ACSM World Congress on Basic Research in Regenerative or contact Lisa Ramage to get in touch with the moderators.